Unlocking Commercial Value from Medicines
Strategy - Design - Implementation Delivering results to Pharma, Biopharma and Pharmacy
Expertise Across Product Strategy - Commercialization - Business Development - Innovation Services
Transformative Solutions
Translational Product Development
Commercial Strategy & Execution
Business Development & Licensing
505(b)(2) & Specialty Generics
Market Access & Channel Management
Operational & Manufacturing Insight
Why CLX
Featured Thought Leadership
Labeling Isn’t a Regulatory Artifact. It’s a Strategic Asset
Most teams treat labeling as something to negotiate at the...
Why “Clinically Equivalent” Is a Commercial Dead End
“Clinically equivalent” may satisfy regulators.It rarely excites clinicians, hospitals, or...
Founder Authority
CLX is led by Jeff Herzfeld, Pharm.D.,MBA, a pharmaceutical executive with experience spanning clinical pharmacy, product development, manufacturing operations, commercial management, business development, and executive leadership across specialty and hospital-focused pharmaceuticals.
Advisory Across the Pharmaceutical Value Chain
CLX supports clients across specialty pharma, emerging biopharma, CDMOs, SaaS healthcare platforms, private equity portfolios, and hospital-focused manufacturers. Services are designed to align strategy with execution while maintaining regulatory, access, and patient considerations.
